ThursdayJan 25, 2018 3:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Offers Potentially Safer Method of Delivering Drug Therapies

Only company in the world with patent for the oral or ingestible delivery of all non-psychoactive cannabinoids Uplisted to OTCQX® Best Market Licensing model generates profit margins in excess of 90 percent A new report by the National Academies of Sciences, Engineering and Medicine is the most comprehensive analysis of existing research on e-cigarettes, according to the New York Times (http://cnw.fm/Eay21). While warning against the risk of nicotine addiction posed by vaping, the report claimed “that the devices are safer than traditional smoking products and may help smokers quit, citing conclusive proof that switching can reduce smokers’ exposure to deadly…

Continue Reading

TuesdayJan 23, 2018 3:47 pm

Grey Cloak Tech’s (GRCK) Recent Eqova Acquisition Positions the Company for Growth on Booming CBD Market

Hemp-derived cannabidiol (CBD) sales projected to surpass $1 billion in five years Grey Cloak Tech has acquired Eqova Life Sciences, an established producer of a range of clinical-grade CBD products This acquisition strengthens Grey Cloak’s position in this market sector and is likely to accelerate its growth On the back of several forecasts of explosive growth in the cannabidiol (CBD) market, Grey Cloak Tech, Inc. (OTCQB: GRCK) has made a strategic decision to focus its efforts in this sector. The Hemp Business Journal reports projected growth of 700 percent by 2020, to reach annual sales of $2.1 billion, according to…

Continue Reading

TuesdayJan 23, 2018 1:07 pm

Disrupting Drug Delivery Platform Keeps Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Portfolio Growing

Patented technology promotes healthier administration of active pharmaceutical ingredients, including cannabidiol (CBD), psychoactive cannabinoids (THC), nicotine, fat soluble vitamins and nonsteroidal anti-inflammatory drugs Active pharmaceutical ingredient market expected to exceed $239 billion by 2025 19 patent applications filed in U.S. and internationally encompassing 44 countries Lab tests in 2018 include topical CBD skin cream, nicotine in edible formats Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million…

Continue Reading

TuesdayJan 16, 2018 2:03 pm

Earth Science Tech, Inc. (ETST) is “One to Watch”

Biotech company focused on production of cutting-edge industrial hemp, cannabis/cannabidiol (CBD) products R&D efforts include nutraceuticals, pharmaceuticals, bioceuticals, phytoceuticals and cosmeceuticals catering to health, wellness and alternative medicine markets International provisional patent application targets CBD’s powerful medicinal benefits Integration of CBD molecule with generic drug molecules opens new medical frontier U.S. consumer market for cannabinoid-based pharmaceuticals estimated at $50 billion by 2029 Medical diagnostic device MSN-2 slated for clinical tests to validate detection of various STDs Global market for diagnostic testing of STDs expected to reach $108.5 billion by 2019 Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050